Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica-Reference-Cited by-同舟云学术

Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica

Published:2007-05-01 Issue:9 Volume:146 Page:631
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Salvarani Carlo¹,Macchioni PierLuigi¹,Manzini Carlo¹,Paolazzi Giuseppe¹,Trotta Aldo¹,Manganelli Paolo¹,Cimmino Marco¹,Gerli Roberto¹,Catanoso Maria Grazia¹,Boiardi Luigi¹,Cantini Fabrizio¹,Klersy Catherine¹,Hunder Gene G.¹

Affiliation:

1. From the Arcispedale S. Maria Nuova, Reggio Emilia, Italy; Policlinico di Modena, Modena, Italy; Ospedale S. Chiara, Trent, Italy; Policlinico S. Salvatore, L'Aquila, Italy; Ospedale Maggiore, Parma, Italy; Università di Genova, Genoa, Italy; Università di Perugia, Perugia, Italy; Ospedale di Prato, Prato, Italy; Istituto di Ricovero e Cura a Carattere Scientifico, Fondazione Policlinico San Matteo, Pavia, Italy; and Mayo Clinic, Rochester, Minnesota.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective Study;Rheumatology and Therapy;2024-08-09

2. The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials;Autoimmunity Reviews;2024-07

3. Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development;Expert Opinion on Investigational Drugs;2024-06-16

4. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis;Expert Opinion on Emerging Drugs;2024-01-02

5. Large and medium vessel vasculitides;The Rose and Mackay Textbook of Autoimmune Diseases;2024